李宗㟨精品72集,黄图能看见奶头

About

SANTHERA

Santhera Pharmaceuticals is a Swiss specialty pharmaceutical company committed to developing and commercializing innovative medicines to meet the needs of patients living with rare and other diseases with high unmet medical needs.

Our focus

We are focusing on the development of treatments for neuromuscular and pulmonary diseases that currently lack treatment options, such as Duchenne muscular dystrophy (DMD), congenital muscular dystrophy (CMD) and cystic fibrosis (CF).

李宗㟨精品72集,黄图能看见奶头We have dedicated more than a decade to researching potential treatments in our ongoing mission to make effective medicines available for these often overlooked, life-altering diseases. We are passionate about improving patients’ quality of life and our vision is to be a leader in providing treatments for rare diseases in these areas with high unmet medical needs.

Our history

Santhera Pharmaceuticals was founded in September 2004 through the merger of two start-up biotech companies, MyoContract AG (Switzerland) and Graffinity Pharmaceuticals AG (Germany).

李宗㟨精品72集,黄图能看见奶头Santhera’s headquarters are located in Pratteln, Switzerland (near Basel), with subsidiaries in Germany, the UK, Italy, the Netherlands, Liechtenstein, the US and Canada.

Santhera’s shares have been listed on the SIX Swiss Exchange under the ticker “SANN” since November 2006.

From the beginning, we have been committed to helping patients through the discovery, development and commercialization of medicines. Since 2004, we have developed our pipeline by conducting numerous clinical studies in Europe and North America.

李宗㟨精品72集,黄图能看见奶头In September 2015, we received our first approval, the European Marketing Authorization, for Raxone in the treatment of patients with LHON. This makes Raxone the first and only medicine to be approved for this condition. Indeed, it is the first to be approved for any mitochondrial disorder: a major milestone in addressing the unmet medical need represented by this group of rare diseases.

Meet our Board of Directors

Elmar Schnee

李宗㟨精品72集,黄图能看见奶头Chairman of the Board and Member of the Compensation Committee

Read more

Martin Gertsch

Member of the Board and Chairman of the Audit Committee

Read more

​Philipp Gutzwiller

Board Member and Member of the Audit Committee

Read more

Thomas Meier

李宗㟨精品72集,黄图能看见奶头Founder, Board Member and Chairman of the Scientific Committee

Read more

Patrick Vink

李宗㟨精品72集,黄图能看见奶头Board Member and Chairman of the Compensation Committee

Read more

Meet our Executive Management team

Günther Metz

Head Business Development, EVP

Read more

Kristina Sjöblom Nygren

李宗㟨精品72集,黄图能看见奶头Chief Medical Officer & Head Development, EVP

Read more

Oliver Strub

李宗㟨精品72集,黄图能看见奶头General Counsel & Secretary to the Board, EVP

Read more